Portfolio company
Duplicat
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence technology to accelerate molecular discovery and enhance drug compound identification for pharmaceutical businesses.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Khumbu
This company develops artificial intelligence models for molecular biology and protein-ligand interactions to accelerate drug discovery for the pharmaceutical industry.
Variartional
This company develops generative artificial intelligence to accelerate the discovery and optimization of novel small molecules for biopharmaceutical researchers and drug developers.
Arrepath
This company develops oral small-molecule drugs for the pharmaceutical industry using artificial intelligence and machine learning workflows.
DreamFold
This company develops generative AI models for protein design to discover new therapeutic drugs for pharmaceutical researchers and clinicians.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Deep Origin
This company provides a computational drug discovery platform for biopharmaceutical researchers to simulate molecular properties and accelerate therapeutic development.
Deeplife
This company develops a cellular digital twin platform using artificial intelligence and multi-omics data to accelerate drug discovery for biotechnology and pharmaceutical researchers.
